Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | rHuPH20 |
| Trade Name | |
| Synonyms | Hylenex |
| Drug Descriptions |
rHuPH20 is recombinant human hyaluronidase lacking the GPI anchor domain, which may enhance dispersion of substances delivered subcutaneously (PMID: 25967925, PMID: 16876899, PMID: 30744432). |
| DrugClasses | |
| CAS Registry Number | 757971-58-7 |
| NCIT ID | C61504 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Amivantamab-vmjw + Lazertinib + rHuPH20 | Amivantamab-vmjw Lazertinib rHuPH20 | 0 | 1 |
| Amivantamab-vmjw + rHuPH20 | Amivantamab-vmjw rHuPH20 | 0 | 1 |
| Atezolizumab + rHuPH20 | Atezolizumab rHuPH20 | 0 | 2 |
| Daratumumab + Lenalidomide + rHuPH20 | Daratumumab Lenalidomide rHuPH20 | 0 | 1 |
| Daratumumab + rHuPH20 | Daratumumab rHuPH20 | 0 | 2 |
| Ipilimumab + Nivolumab + rHuPH20 | Ipilimumab Nivolumab rHuPH20 | 0 | 1 |
| Nivolumab + Relatlimab + rHuPH20 | Nivolumab Relatlimab rHuPH20 | 0 | 2 |
| Nivolumab + rHuPH20 | Nivolumab rHuPH20 | 0 | 2 |
| rHuPH20 | rHuPH20 | 0 | 0 |